<DOC>
	<DOCNO>NCT00317031</DOCNO>
	<brief_summary>The primary objective directly compare efficacy acamprosate , naltrexone placebo relapse prevention alcoholic .</brief_summary>
	<brief_title>Individually Adapted Therapy Alcoholism</brief_title>
	<detailed_description>The primary objective directly compare efficacy acamprosate , naltrexone placebo relapse prevention alcoholic . The secondary objective establish association patient ' motivational type drug effect . The aim improve alcoholism treatment identify characteristic response specific pharmacological relapse prevention . Such item could allow individually adapt pharmacotherapy alcoholism . Specifically , study possible dependence efficacy naltrexone and/or acamprosate different motivational type ( reward versus relief crave ) genetic profile refer glutamatergic opioidergic candidate gene . Lastly , longterm cost cost-effectiveness different treatment strategy alcoholics choose study establish .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Acamprosate</mesh_term>
	<criteria>1 . Participants current DSMIV/ICD 10 diagnosis alcohol dependence . 2 . Participants must minimum 14 drink ( female ) 21 drink ( male ) average per week consecutive 30day period 90day period prior initiation abstinence , must two day heavy drinking ( defined 4 drink female 5 drink male ) 90day period prior initiation abstinence . 3 . Participants must minimum 72 hour abstinence significant withdrawal symptom ( CIWA &lt; 8 ) prior randomization . 4 . At least 2 week inpatient treatment . 5 . Participants abstinent maximum 28 day prior randomization . 6 . Participants willing seek additional psychotherapy first 6 month study except attendance mutual help group . 7 . Participants sign witness declaration inform consent . 1 . Participants meet current DSMIV criterion bipolar disorder , schizophrenia , bulimia/anorexia , dementia , psychological disorder medication indicate , Axis I disorder medicate severe enough require medication . 2 . Participants require psychopharmacotherapy . 3 . Participants require therapy medication pose safety issue . 4 . Participants current abuse psychoactive drug show positive drug test urine screen . 5 . Participants lifetime diagnosis dependence psychoactive drug except nicotine habitual caffeine use . 6 . Participants significant medical disorder would increase potential risk study treatment interfere study participation . 7 . Participants abnormal AST ALT ( 5 time normal level ) . 8 . Participants pregnant nursing infant ( ) . 9 . Women childbearing year without effective contraceptive method . 10 . Participants develop sensitivity study medication . 11 . Participants illiterate unable read write German .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Alcoholism</keyword>
	<keyword>Drug Therapy</keyword>
</DOC>